v3.26.1
INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Summarized Joint Venture Financial Statement Activity on 100% Basis (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
May 31, 2026
Feb. 22, 2026
Nov. 23, 2025
Aug. 24, 2025
May 25, 2025
Feb. 23, 2025
Nov. 24, 2024
Aug. 25, 2024
May 31, 2026
May 25, 2025
May 26, 2024
Schedule of Equity Method Investments [Line Items]                      
Gross margin $ 1,603.5 $ 1,366.9 $ 1,692.5 $ 1,532.8 $ 1,474.0 $ 1,639.1 $ 1,931.1 $ 1,688.8      
(Loss) earnings after income taxes                 $ (85.3) $ 2,318.9 $ 2,518.6
Current assets 4,618.3       5,275.7       4,618.3 5,275.7  
Current liabilities 6,774.1       7,857.3       6,774.1 7,857.3  
Equity Method Investments                      
Schedule of Equity Method Investments [Line Items]                      
Sales to joint ventures                 2,020.2 1,970.4 2,037.8
Gross margin                 697.5 686.8 672.2
(Loss) earnings before income taxes                 (73.6) 89.4 145.2
(Loss) earnings after income taxes                 (112.1) 61.5 119.9
Current assets 707.4       751.0       707.4 751.0  
Noncurrent assets 632.5       788.3       632.5 788.3  
Current liabilities 1,302.6       1,314.1       1,302.6 1,314.1  
Noncurrent liabilities $ 116.3       $ 96.3       116.3 96.3  
CPW                      
Schedule of Equity Method Investments [Line Items]                      
Sales to joint ventures                 1,678.5 1,647.3 1,718.5
HDJ                      
Schedule of Equity Method Investments [Line Items]                      
Sales to joint ventures                 $ 341.7 $ 323.1 $ 319.3